Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $1.47 Million - $1.85 Million
-23,843 Reduced 1.61%
1,452,716 $111 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $15.1 Million - $20.3 Million
-217,390 Reduced 12.83%
1,476,559 $102 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $27.1 Million - $31.4 Million
-332,877 Reduced 16.42%
1,693,949 $160 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $1.17 Million - $1.33 Million
-15,731 Reduced 0.77%
2,026,826 $168 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $14.8 Million - $19 Million
216,804 Added 11.87%
2,042,557 $152 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $8.08 Million - $10.5 Million
-98,129 Reduced 5.1%
1,825,753 $151 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $4.47 Million - $6.63 Million
-51,652 Reduced 2.61%
1,923,882 $183 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $13.4 Million - $16.9 Million
-131,560 Reduced 6.24%
1,975,534 $189 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $4.59 Million - $5.64 Million
-43,146 Reduced 2.01%
2,107,094 $273 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $8.06 Million - $9.61 Million
-78,314 Reduced 3.51%
2,150,240 $243 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $680,780 - $850,651
-8,120 Reduced 0.36%
2,228,554 $231 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $13.3 Million - $15.3 Million
-168,889 Reduced 7.02%
2,236,674 $187 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $172 Million - $219 Million
2,404,717 Added 284245.5%
2,405,563 $219 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $48,678 - $65,099
846 New
846 $58,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Harding Loevner LP Portfolio

Follow Harding Loevner LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.